Why the Divergence Between U.S. and Global Stocks Is Cause for Concern

The video discusses the divergence between US equities and global markets, highlighting concerns about sustainability. It analyzes the biotech sector's strong performance and potential buying opportunities, while also examining the healthcare sector's technical trends and leadership role. The discussion emphasizes caution in US equities and identifies healthcare as a potential bright spot.

What is the main concern about the divergence between US equities and the rest of the world?

• Both US equities and the rest of the world are in an uptrend.

• US equities are in a downtrend while the rest of the world is in an uptrend.

• Both US equities and the rest of the world are in a downtrend.

• US equities are in an uptrend while the rest of the world is in a downtrend.

What is the current trend in the biotech sector according to the analysis?

• Biotech is highly volatile with no clear trend.

• Biotech is in an established uptrend.

• Biotech is in a sideways trend.

• Biotech is in a downtrend.

What is a potential downside target for biotech if it weakens relative to the S&P 500?

• The 200-day moving average.

• The 300-day moving average.

• The 100-day moving average.

• The 50-day moving average.

Which sector has taken a leadership role when some technology stocks have struggled?

• Consumer Discretionary

• Healthcare

• Financials

• Energy

What does an RSI above 70 typically indicate?

• A market crash.

• A strong buying opportunity.

• A short-term correction.

• A long-term uptrend.